Surveillance of antimicrobial use and antimicrobial resistance in intensive care units (SARI): 1. Antimicrobial use in German intensive care units

Intensive Care Medicine

Volumn 30, Issue 6, 2004, Pages 1089-1096

  Meyer, Elisabeth ^a   Schwab, Frank ^b,d   Jonas, Daniel ^a   Rueden, Henning ^b,d   Gastmeier, Petra ^c,d   Daschner, Franz D ^a,d  

^a UNIVERSITY OF FREIBURG   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d Natl Ref Ctr Survlnc N   (Germany)

Author keywords

Antimicrobial use; Intensive care unit; SARI; Surveillance

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFACLOR; CEFALEXIN; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFOTIAM; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN; CLAVULANIC ACID; DOXYCYCLINE; FLUCLOXACILLIN; GLYCOPEPTIDE; IMIDAZOLE DERIVATIVE; MACROLIDE; MEROPENEM; MEZLOCILLIN; OXACILLIN; PENICILLIN G; PIPERACILLIN; QUINOLONE DERIVATIVE; TAZOBACTAM; TETRACYCLINE; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CORRELATION ANALYSIS; DRUG RESPONSE; DRUG USE; EPIDEMIOLOGICAL DATA; HEALTH SURVEY; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; PROSPECTIVE STUDY; QUALITY CONTROL; REVIEW; RISK FACTOR;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG UTILIZATION REVIEW; GERMANY; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 3042640075     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-004-2266-9     Document Type: Review

References (21)

1. Anonymous (2001) Proposal for a council recommendation on the prudent use of antimicrobial agents in human medicine. Official Journal of the European Communities L 34/13, 13502-13501
2. Gaynes R (1997) The impact of antimicrobial use on the emergence of antimicrobial-resistant bacteria in hospitals. Infect Dis Clin North Am 11:757-765
3. Paladino JA (2000) Economic justification of antimicrobial management programs: implications of antimicrobial resistance. Am J Health Syst Pharm 57 (Suppl 2):S10-S12
4. Kollef MH, Fraser VJ (2001) Antibiotic resistance in the intensive care unit. Ann Intern Med 134:298-314
5. Weinstein RA (2001) Controlling antimicrobial resistance in hospitals: infection control and use of antibiotics. Emerg Infect Dis 7:188-192
6. Geffers C, Koch J, Sohr D, Nassauer A, Daschner F, Rueden H, Gastmeier P (2000) [Establishment of a national database for ICU-associated infections. First results from the "Krankenhaus-Infections-Surveillance-System" (KISS)]. Anaesthesist 49:732-737
7. Meyer E, Jonas D, Schwab F, Rueden H, Gastmeier P, Daschner FD (2003) Design of a surveillance system of antibiotic use and bacterial resistance in German intensive care units (SARI). Infection 31:208-215
8. ATC index with DDDs (1999) WHO Collaborating Centre for Drug Statistics Methodology, Oslo
9. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections. Am J Infect Control 16:128-140
10. National nosocomial infections surveillance (NNIS) system report, data summary from January 1992 to June 2002 (2002) Am J Infect Control 30:458-475
11. National nosocomial infections surveillance (NNIS) system report. Data summary from January 1992 to June 2001 (2001) Am J Infect Control 29:404-421
12. Gastmeier P, Schwab F, Geffers C, Rueden H (2002) Is the strict isolation of MRSA patients really necessary? Analysis of data from the German nosocomial infection surveillance system KISS. Fifth International Conference of the Hospital Infection Society, Edingbugh, abstact P5.03
13. Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE Jr, Archibald LK, Gaynes RP, Tenover FC (1999) Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project intensive care antimicrobial resistance epidemiology (ICARE) hospitals. Clin Infect Dis 29:245-252
14. Walther SM, Erlandsson M, Burman LG, Cars O, Gill H, Hoffman M, Isaksso B, Kahlmeter G, Lindgren S, Nilsson L, Olsson-Liljequist B, Hanberger H (2002) Antibiotic prescription practices, consumption and bacterial resistance in a cross section of Swedish intensive care units. Acta Anaesthesiol Scand 46:1075-1081
15. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick, RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA (2002) Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR 51:1-29
16. Mertens R, Kegels G, Stroobant A, Reybrouck G, Lamotte JM, Potvliege C, Van Casteren V, Lauwers S, Verschraegen G, Wauters G (1987) The national prevalence survey of nosocomial infections in Belgium, 1984. J Hosp Infect 9:219-229
17. Ruden H, Gastmeier P, Daschner FD, Schumacher M (1997) Nosocomial and community-acquired infections in Germany. Summary of the results of the First National Prevalence Study (NIDEP). Infection 25:199-202
18. Vaque J, Rossello J, Arribas JL (1999) Prevalence of nosocomial infections in Spain: EPINE study 1990-1997, EPINE Working Group. J Hosp Infect 43 (Suppl):S105-S111
19. Sax H, Pittet D (2002) Interhospital differences in nosocomial infection rates: importance of case-mix adjustment. Arch Intern Med 162:2437-2442
20. OECD Health Data 2000 (2000) OECD, Paris
21. Emmerson M (2000) Antibiotic usage and prescribing policies in the intensive care unit. Intensive Care Med 26 (Suppl 1):S26-S30